VERICEL CORPORATION Lessee, Operating Lease, Liability, to be Paid, Year Five
VERICEL CORPORATION (VCEL) had Lessee, Operating Lease, Liability, to be Paid, Year Five of $15.56 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2026-02-26
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $15.56M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $15.15M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $6.73M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $6.53M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2025-12-31 | $15.56M 10-K · filed 2026-02-26 |
| 2024-12-31 | $15.15M 10-K · filed 2025-02-27 |
| 2022-12-31 | $6.73M 10-K · filed 2023-02-23 |
| 2021-12-31 | $6.53M 10-K · filed 2022-02-24 |
| 2020-12-31 | $6.34M 10-K · filed 2021-02-24 |
| 2019-12-31 | $5.30M 10-K · filed 2020-02-25 |
| 2019-09-30 | $5.29M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $4.90M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $4.90M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |